30083844|t|Does Dexmedetomidine Ameliorate Postoperative Cognitive Dysfunction? A Brief Review of the Recent Literature.
30083844|a|PURPOSE OF REVIEW: Postoperative cognitive dysfunction (POCD) occurs in 20-50% of postsurgical patients with a higher prevalence in elderly patients and patients with vascular disease and heart failure. In addition, POCD has been associated with many negative outcomes, such as increased hospital length of stay, increased rates of institutionalization, and higher patient mortality. This brief review discusses select evidence suggesting an association between neuroinflammation and POCD and whether the use of dexmedetomidine, a short-acting alpha 2 agonist, may ameliorate the incidence of POCD. We review the recent evidence for neuroinflammation in POCD, dexmedetomidine's properties in reducing inflammatory-mediated brain injury, and clinical studies of dexmedetomidine and POCD. RECENT FINDINGS: There is evidence to support the anti-inflammatory and immunomodulatory effects of dexmedetomidine in animal models. Several clinical investigations have demonstrated favorable outcomes using dexmedetomidine over placebo for the reduction of postoperative delirium. Few studies have used high-quality endpoints for the assessment of POCD and no demonstrable evidence supports the use of dexmedetomidine for the prevention of POCD. While evidence exists for the neural anti-inflammatory properties of dexmedetomidine, human trials have yielded incomplete results concerning its use for the management of POCD. Dexmedetomidine may reduce acute postoperative delirium, but further studies are needed prior to recommending the use of dexmedetomidine for the direct reduction of POCD.
30083844	5	20	Dexmedetomidine	Chemical	MESH:D020927
30083844	32	67	Postoperative Cognitive Dysfunction	Disease	MESH:D000079690
30083844	129	164	Postoperative cognitive dysfunction	Disease	MESH:D000079690
30083844	166	170	POCD	Disease	MESH:D000079690
30083844	205	213	patients	Species	9606
30083844	250	258	patients	Species	9606
30083844	263	271	patients	Species	9606
30083844	277	293	vascular disease	Disease	MESH:D014652
30083844	298	311	heart failure	Disease	MESH:D006333
30083844	326	330	POCD	Disease	MESH:D000079690
30083844	475	482	patient	Species	9606
30083844	572	589	neuroinflammation	Disease	MESH:D000090862
30083844	594	598	POCD	Disease	MESH:D000079690
30083844	622	637	dexmedetomidine	Chemical	MESH:D020927
30083844	703	707	POCD	Disease	MESH:D000079690
30083844	743	760	neuroinflammation	Disease	MESH:D000090862
30083844	764	768	POCD	Disease	MESH:D000079690
30083844	770	785	dexmedetomidine	Chemical	MESH:D020927
30083844	811	823	inflammatory	Disease	MESH:D007249
30083844	833	845	brain injury	Disease	MESH:D001930
30083844	871	886	dexmedetomidine	Chemical	MESH:D020927
30083844	891	895	POCD	Disease	MESH:D000079690
30083844	952	964	inflammatory	Disease	MESH:D007249
30083844	997	1012	dexmedetomidine	Chemical	MESH:D020927
30083844	1106	1121	dexmedetomidine	Chemical	MESH:D020927
30083844	1156	1178	postoperative delirium	Disease	MESH:D000071257
30083844	1247	1251	POCD	Disease	MESH:D000079690
30083844	1301	1316	dexmedetomidine	Chemical	MESH:D020927
30083844	1339	1343	POCD	Disease	MESH:D000079690
30083844	1387	1399	inflammatory	Disease	MESH:D007249
30083844	1414	1429	dexmedetomidine	Chemical	MESH:D020927
30083844	1431	1436	human	Species	9606
30083844	1517	1521	POCD	Disease	MESH:D000079690
30083844	1523	1538	Dexmedetomidine	Chemical	MESH:D020927
30083844	1556	1578	postoperative delirium	Disease	MESH:D000071257
30083844	1644	1659	dexmedetomidine	Chemical	MESH:D020927
30083844	1688	1692	POCD	Disease	MESH:D000079690
30083844	Negative_Correlation	MESH:D020927	MESH:D000079690
30083844	Negative_Correlation	MESH:D020927	MESH:D001930
30083844	Negative_Correlation	MESH:D020927	MESH:D000071257
30083844	Negative_Correlation	MESH:D020927	MESH:D007249

